Early Knee Arthritis Management
Do you suffer from knee pain? Is it activity-dependent? Too young for a knee replacement?
As an orthopedic surgeon, I am seeing a younger cohort of patients with knee osteoarthritis than ever before. These young patients are active, have demanding jobs and lifestyles and are unwilling or unable to reduce or modify their activities to compensate for their arthritic pain. This provides us with a difficult challenge to manage these patients who are currently not surgical candidates for knee arthroscopy or knee replacement.
In general, activity modification, weight reduction and the use of anti-inflammatory medications around the times of increased activity and bracing are the mainstays of early knee osteoarthritis treatment.
As technology has evolved, we have a better understanding at the molecular level, what is happening at the cartilage surface and how to counter-act further cartilage degradation and progression of arthritis.
We now have at our disposal a new tool specifically designed for early to moderate knee osteoarthritis. It works at the cartilage surface, blocking receptors that degrade the cartilage as well as alters the knee joint synovial fluid composition, to one more favourable to regeneration and cartilage health. Let me introduce you to nSTRIDE APS injection therapy, which is a platelet-rich plasma (PRP) derivative with more concentrated white blood cells and growth factors to help protect and reduce your arthritic pain. Please review the videos below.
If you are interested in having this injection for your knees, please have your doctor make a referral to Dr. Tsuji today!
Please fax the referral to: (905) 666-4523
